1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) — National Institute on Aging (NIA). Designed for early-stage clinician-scientists to advance their research and leadership skills specifically in their specialty and the broader field of aging and geriatric research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Early-stage clinician-scientists with faculty-level research support history. Confirm the full requirements in the official notice before applying.
Applications for Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed) are due November 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH) — National Institute on Aging (NIA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01) is sponsored by National Institutes of Health (NIH) — National Institute on Aging (NIA). Supports health services and educational research interventions designed to improve care delivery, provider training, quality, equity, and health outcomes for older adults from health disparity populations.
Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) — National Institute on Aging (NIA). Supports small research projects on Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) specifically tailored for new and early-stage investigators at universities and academic institutions.
NIH's RFI on administrative burden (NOT-OD-26-118) takes comments through December 8, 2026. It asks seven questions, lists eight reforms already made, and warns that responses may be posted unredacted. Here is what NIH is really asking for, what it can and cannot change alone, and how researchers and research offices should respond.
Read articleOn November 2, 2026, NIH released NOT-OD-27-006, a draft update to its Policy for Data and Safety Monitoring. As summarized by Harvard's research integrity office, the draft would extend risk-based monitoring from clinical trials to all NIH-supported clinical research, drop the blanket DSMB requirement for Phase 3 and multi-site trials, and require an NIH-approved monitoring plan scaled to risk, effective for applications six months after the final policy. Comments are due January 6, 2027. What it changes and how to respond.
Read articleR&D World's count of NIH RePORTER data shows 13,686 new awards in FY2026, up 21% from 11,272 in FY2025, while total extramural grants fell to about 56,600. New R01s hit 4,960. What the split means for FY2027 applicants.
Read article